Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N M Barth

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
The Western Journal of Medicine|February 1, 1996
Malignant melanoma and pregnancy ten questionsR O Dillman, L A Vandermolen, N M Barth, et al.
Cancer Biotherapy & Radiopharmaceuticals|August 1, 1997
Long-term survival after continuous infusion interleukin-2R O Dillman, C Church, N M Barth, et al.
Pediatric Neurosurgery|October 10, 2002
Torsion of a lumbar nerve root schwannomaSami Khoshyomn, Konrad N M Barth, Robert A Christman, et al.
Breast Cancer Research and Treatment|January 1, 1996
High-dose chemotherapy with autologous stem cell rescue in breast cancerR O Dillman, N M Barth, S K Nayak, et al.
Journal of the National Cancer Institute|August 15, 1990
Recombinant interleukin-2 and adoptive immunotherapy alternated with dacarbazine therapy in melanoma: a National Biotherapy Study Group trialR O Dillman, R K Oldham, N M Barth, et al.
Cancer Biotherapy|January 1, 1995
The integration of high-dose chemotherapy and biotherapy: initial 5-year experience with autologous bone marrow transplantation in a comprehensive community cancer centerR O Dillman, N M Barth, K Mahdavi, et al.
Molecular Biotherapy|June 1, 1991
Continuous infusion of interleukin-2 and cyclophosphamide as treatment of advanced cancers: a National Biotherapy Study Group TrialR K Oldham, J Stark, N M Barth, et al.
Cancer|May 12, 1998
Interferon-alpha and chemohormonal therapy for patients with advanced melanoma: final results of a phase I-II study of the Cancer Biotherapy Research Group and the Mid-Atlantic Oncology ProgramJ J Stark, R O Dillman, R Schulof, et al.
Cancer Biotherapy & Radiopharmaceuticals|April 1, 1997
Tumor localization by tumor infiltrating lymphocytes labeled with indium-111 in patients with metastatic renal cell carcinoma, melanoma, and colorectal cancerR O Dillman, S R Hurwitz, P M Schiltz, et al.
Cancer Biotherapy & Radiopharmaceuticals|March 31, 2001
Treatment of kidney cancer with autologous tumor cell vaccines of short-term cell lines derived from renal cell carcinomaR O Dillman, N M Barth, L A VanderMolen, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
The Western Journal of Medicine|February 1, 1996
Malignant melanoma and pregnancy ten questionsR O Dillman, L A Vandermolen, N M Barth, et al.
Cancer Biotherapy & Radiopharmaceuticals|August 1, 1997
Long-term survival after continuous infusion interleukin-2R O Dillman, C Church, N M Barth, et al.
Pediatric Neurosurgery|October 10, 2002
Torsion of a lumbar nerve root schwannomaSami Khoshyomn, Konrad N M Barth, Robert A Christman, et al.
Breast Cancer Research and Treatment|January 1, 1996
High-dose chemotherapy with autologous stem cell rescue in breast cancerR O Dillman, N M Barth, S K Nayak, et al.
Journal of the National Cancer Institute|August 15, 1990
Recombinant interleukin-2 and adoptive immunotherapy alternated with dacarbazine therapy in melanoma: a National Biotherapy Study Group trialR O Dillman, R K Oldham, N M Barth, et al.
Cancer Biotherapy|January 1, 1995
The integration of high-dose chemotherapy and biotherapy: initial 5-year experience with autologous bone marrow transplantation in a comprehensive community cancer centerR O Dillman, N M Barth, K Mahdavi, et al.
Molecular Biotherapy|June 1, 1991
Continuous infusion of interleukin-2 and cyclophosphamide as treatment of advanced cancers: a National Biotherapy Study Group TrialR K Oldham, J Stark, N M Barth, et al.
Cancer|May 12, 1998
Interferon-alpha and chemohormonal therapy for patients with advanced melanoma: final results of a phase I-II study of the Cancer Biotherapy Research Group and the Mid-Atlantic Oncology ProgramJ J Stark, R O Dillman, R Schulof, et al.
Cancer Biotherapy & Radiopharmaceuticals|April 1, 1997
Tumor localization by tumor infiltrating lymphocytes labeled with indium-111 in patients with metastatic renal cell carcinoma, melanoma, and colorectal cancerR O Dillman, S R Hurwitz, P M Schiltz, et al.
Cancer Biotherapy & Radiopharmaceuticals|March 31, 2001
Treatment of kidney cancer with autologous tumor cell vaccines of short-term cell lines derived from renal cell carcinomaR O Dillman, N M Barth, L A VanderMolen, et al.
Pageof 2